Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,054,647
-
Share change
-
+4,096,322
-
Total reported value
-
$761,820,800
-
Put/Call ratio
-
0%
-
Price per share
-
$21.73
-
Number of holders
-
86
-
Value change
-
+$90,569,995
-
Number of buys
-
46
-
Number of sells
-
40
Institutional Holders of AIMMUNE THERAPEUTICS INC - COM (AIMT) as of Q1 2017
As of 31 Mar 2017 AIMMUNE THERAPEUTICS INC - COM (AIMT) had 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 35,054,647 shares of stock of the company.
Largest 10 holders included Foresite Capital Management II, LLC, FMR LLC, Aisling Capital LLC, WELLINGTON MANAGEMENT GROUP LLP, TLP GROUP LLC, VANGUARD GROUP INC, BlackRock Inc., EAGLE ASSET MANAGEMENT INC, ADAGE CAPITAL PARTNERS GP, L.L.C., and Palo Alto Investors, LLC.
This table shows 86 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.